VolitionRx Limited Form 8-K Filing

VolitionRx Limited reported on September 9, 2026, regarding the conversion of senior secured convertible promissory notes. In connection with its obligations under notes issued to Lind Global Asset Management XII LLC, the company issued an aggregate of 706,214 shares of common stock on September 2, 2026, to satisfy a $250,000 conversion obligation. Additionally, on September 10, 2026, the company issued an aggregate of 707,236 shares of common stock to satisfy a $215,000 conversion obligation. These shares were issued in reliance on exemptions from registration under the Securities Act of 1933. As of September 14, 2026, the company had 27,903,326 shares of common stock issued and outstanding. The filing was signed by Cameron Reynolds, Chief Executive Officer & President, on September 15, 2026.